124
Views
42
CrossRef citations to date
0
Altmetric
Original Research

A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy

, , , , &
Pages 7469-7482 | Published online: 13 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yanhai Xi, Weiheng Wang, Liang Ma, Ning Xu, Changgui Shi, Guohua Xu, Hailong He & Wenming Pan. (2022) Alendronate modified mPEG-PLGA nano-micelle drug delivery system loaded with astragaloside has anti-osteoporotic effect in rats. Drug Delivery 29:1, pages 2386-2402.
Read now
Qian Zhao, Chang Liu, Ying Xie, Mengjia Tang, Guojing Luo, Xiang Chen, Li Tian & Xijie Yu. (2020) Lung Cancer Cells Derived Circulating miR-21 Promotes Differentiation of Monocytes into Osteoclasts. OncoTargets and Therapy 13, pages 2643-2656.
Read now
Yabing Wang, Jian Xie, Zexin Ai & Jiansheng Su. (2019) Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis. International Journal of Nanomedicine 14, pages 7839-7849.
Read now
Ana Cláudia Lima, Helena Ferreira, Rui L. Reis & Nuno M. Neves. (2019) Biodegradable polymers: an update on drug delivery in bone and cartilage diseases. Expert Opinion on Drug Delivery 16:8, pages 795-813.
Read now

Articles from other publishers (38)

Jianglin Hou, Da Liu, Jihui Zhao, Sen Qin, Senxiang Chen & Zimo Zhou. (2023) Long non-coding RNAs in osteoporosis: from mechanisms of action to therapeutic potential. Human Cell 36:3, pages 950-962.
Crossref
Miguel Gisbert-Garzarán, María Natividad Gómez-Cerezo & María Vallet-Regí. (2023) Targeting Agents in Biomaterial-Mediated Bone Regeneration. International Journal of Molecular Sciences 24:3, pages 2007.
Crossref
Anjali Pant, Joga Singh, Ravi Pratap Barnwal, Gurpal Singh & Bhupinder Singh. (2023) Theranostic Approach for the Management of Osteoporosis. Critical Reviews™ in Therapeutic Drug Carrier Systems 40:3, pages 95-121.
Crossref
Sagar Salave, Dhwani Rana & Derajram Benival. (2022) Dual Targeting Anti-Osteoporotic Therapy Through Potential Nanotherapeutic Approaches. Pharmaceutical Nanotechnology 10:5, pages 384-392.
Crossref
Yongzhi Cui, Zhongying Li, Yuanyuan Guo, Xiangbei Qi, Yuehua Yang, Xiong Jia, Rui Li, Jingyu Shi, Weihang Gao, Zhengwei Ren, Guohui Liu, Qingsong Ye, Zhiping Zhang & Dehao Fu. (2022) Bioinspired Nanovesicles Convert the Skeletal Endothelium-Associated Secretory Phenotype to Treat Osteoporosis. ACS Nano 16:7, pages 11076-11091.
Crossref
Haifeng Liang, Lei Zhou, Zhichao Hu, Yuxiang Ge, Taiwei Zhang, Qing Chen, Ben Wang, Shunyi Lu, Wang Ding, Jian Dong, Fengfeng Xue & Libo Jiang. (2022) Siglec15 Checkpoint Blockade for Simultaneous Immunochemotherapy and Osteolysis Inhibition in Lung Adenocarcinoma Spinal Metastasis via a Hollow Nanoplatform. Small 18:29, pages 2107787.
Crossref
Aaron Schindeler, Lucinda R Lee, Alexandra K O'Donohue, Samantha L Ginn & Craig F Munns. (2022) Curative Cell and Gene Therapy for Osteogenesis Imperfecta. Journal of Bone and Mineral Research 37:5, pages 826-836.
Crossref
Ye Gao, He Xin, Bolei Cai, Le Wang, Qianxin Lv, Yan Hou, Fuwei Liu, Taiqiang Dai & Liang Kong. (2022) RNA interference-based osteoanabolic therapy for osteoporosis by a bone-formation surface targeting delivery system. Biochemical and Biophysical Research Communications 601, pages 86-92.
Crossref
Bongsong Zhang, Juzhi Zhao, Hongji Yan, Yufang Zhao, Hui Tian, Cao Wang, Ruiqi Wang, Jiaming Jin, Yue Chen, Chaofan Yang, Chunfeng LI, Yanwen Jiao, Kaipeng Zheng, Fuxing Zhu & Weiming Tian. (2022) A novel nano delivery system targeting different stages of osteoclasts. Biomaterials Science 10:7, pages 1821-1830.
Crossref
Lifang Gao & Shuang-Qing Zhang. (2022) Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects. Pharmaceuticals 15:4, pages 397.
Crossref
J. Li, F. Jin, M. Cai, T. Lin, X. Wang & Y. Sun. (2021) LncRNA Nron Inhibits Bone Resorption in Periodontitis. Journal of Dental Research 101:2, pages 187-195.
Crossref
Anuradha Pandit, Yasmin Begum, Priyanka Saha & Snehasikta Swarnakar. 2022. Advances in Nanotechnology-Based Drug Delivery Systems. Advances in Nanotechnology-Based Drug Delivery Systems 197 226 .
Mingchao Jin, Jiangbo Nie, Juli Zhu, Jing Li, Tianshun Fang, Juntao Xu, Xuesheng Jiang, Zhuo Chen, Jianyou Li & Fengfeng Wu. (2021) Acacetin inhibits RANKL-induced osteoclastogenesis and LPS-induced bone loss by modulating NFATc1 transcription. Biochemical and Biophysical Research Communications 583, pages 146-153.
Crossref
Meer M. J. Amin, Christopher J. Trevelyan & Neil A. Turner. (2021) MicroRNA-214 in Health and Disease. Cells 10:12, pages 3274.
Crossref
Hanan Aljohani, Linda T. Senbanjo, Mohammed Al Qranei, Joseph P. Stains & Meenakshi A. Chellaiah. (2021) Methylsulfonylmethane Increases the Alveolar Bone Density of Mandibles in Aging Female Mice. Frontiers in Physiology 12.
Crossref
Asier Muñoz, Anxhela Docaj, Maialen Ugarteburu & Alessandra Carriero. (2021) Poor bone matrix quality: What can be done about it?. Current Osteoporosis Reports 19:5, pages 510-531.
Crossref
Rundong Feng, Suryaji Patil, Xin Zhao, Zhiping Miao & Airong Qian. (2021) RNA Therapeutics - Research and Clinical Advancements. Frontiers in Molecular Biosciences 8.
Crossref
Gudrun C. Thurner, Johannes Haybaeck & Paul Debbage. (2021) Targeting Drug Delivery in the Elderly: Are Nanoparticles an Option for Treating Osteoporosis?. International Journal of Molecular Sciences 22:16, pages 8932.
Crossref
Fujun Jin, Junhui Li, Yong-Biao Zhang, Xiangning Liu, Mingxiang Cai, Meijing Liu, Mengyao Li, Cui Ma, Rui Yue, Yexuan Zhu, Renfa Lai, Zuolin Wang, Xunming Ji, Huawei Wei, Jun Dong, Zhiduo Liu, Yifei Wang, Yao Sun & Xiaogang Wang. (2021) A functional motif of long noncoding RNA Nron against osteoporosis. Nature Communications 12:1.
Crossref
Xin Zhao, Suryaji Patil, Fang Xu, Xiao Lin & Airong Qian. (2021) Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis. Biomolecules 11:5, pages 747.
Crossref
Shariqsrijon Sinha Ray, Justin Brits & Kerry Deware. (2021) Osteoporosis and Its Nanotechnology-Based Advanced Treatment—An Overview. Journal of Biomedical Nanotechnology 17:5, pages 809-821.
Crossref
Francesca Salamanna, Alessandro Gambardella, Deyanira Contartese, Andrea Visani & Milena Fini. (2021) Nano-Based Biomaterials as Drug Delivery Systems Against Osteoporosis: A Systematic Review of Preclinical and Clinical Evidence. Nanomaterials 11:2, pages 530.
Crossref
Austin P. Hensley & Audrey McAlinden. (2021) The role of microRNAs in bone development. Bone 143, pages 115760.
Crossref
Shan Tao, Fangying Yu, Yanqing Song, Wentao Zhou, Jianghong Lv, Rui Zhao, Cheng Wang, Fuqiang Hu & Hong Yuan. (2021) Water/pH dual responsive in situ calcium supplement collaborates simvastatin for osteoblast promotion mediated osteoporosis therapy via oral medication. Journal of Controlled Release 329, pages 121-135.
Crossref
James L. Shepherdson, Hongjun Zheng, Ina E. Amarillo, Audrey McAlinden & Marwan Shinawi. (2021) Delineation of the 1q24.3 microdeletion syndrome provides further evidence for the potential role of non-coding RNAs in regulating the skeletal phenotype. Bone 142, pages 115705.
Crossref
Jiawei Pei, Qian Huang, Mili Ji, Xiaohua Chu, Ye Tian, Airong Qian & Peihong Su. 2021. Noncoding RNAs and Bone. Noncoding RNAs and Bone 159 184 .
Malkiet Kaur, Manju Nagpal & Manjinder Singh. (2020) Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment. Current Drug Targets 21:16, pages 1640-1651.
Crossref
Mingwei Huang, Xiaowen Li, Can Zhou, Min Si, Haiyan Zheng, Lianhua Chen & Hongcheng Ding. (2019) Noncoding RNA miR‐205‐5p mediates osteoporosis pathogenesis and osteoblast differentiation by regulating RUNX2. Journal of Cellular Biochemistry 121:10, pages 4196-4203.
Crossref
Robin A. Nadar, Jeroen J.J.P. van den Beucken & Sander C.G. Leeuwenburgh. 2020. Dental Implants and Bone Grafts. Dental Implants and Bone Grafts 251 280 .
Zhe‐Hai Li, He Hu, Xiao‐Yan Zhang, Guo‐Dong Liu, Bo Ran, Pei‐Guang Zhang, Ming‐Mei Liao & Yu‐Chi Wu. (2019) MiR‐291a‐3p regulates the BMSCs differentiation via targeting DKK1 in dexamethasone‐induced osteoporosis. The Kaohsiung Journal of Medical Sciences 36:1, pages 35-42.
Crossref
Lisa J. Robinson, Harry C. Blair, John B. Barnett & Jonathan Soboloff. (2019) The roles of Orai and Stim in bone health and disease. Cell Calcium 81, pages 51-58.
Crossref
Elodie Feurer, Casina Kan, Martine Croset, Elisabeth Sornay‐Rendu & Roland Chapurlat. (2019) Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort. Journal of Bone and Mineral Research 34:6, pages 1074-1085.
Crossref
Xi Sun, Qi Guo, Wenhua Wei, Stephen Robertson, Ying Yuan & Xianghang Luo. (2019) Current Progress on MicroRNA-Based Gene Delivery in the Treatment of Osteoporosis and Osteoporotic Fracture. International Journal of Endocrinology 2019, pages 1-17.
Crossref
Henry C. Hrdlicka, Sun-Kyeong Lee & Anne M. Delany. (2019) MicroRNAs Are Critical Regulators of Osteoclast Differentiation. Current Molecular Biology Reports 5:1, pages 65-74.
Crossref
Kah-Yung Bernard Leong, Yee-Han Chan, Wan Muhamad Asrul Nizam Wan Abdullah, Swee-Hua Erin Lim & Kok-Song Lai. 2018. Transcriptional and Post-transcriptional Regulation. Transcriptional and Post-transcriptional Regulation.
Harshika Awasthi, Dayanandan Mani, Divya Singh & Atul Gupta. (2018) The underlying pathophysiology and therapeutic approaches for osteoporosis. Medicinal Research Reviews 38:6, pages 2024-2057.
Crossref
Annalise Elizabeth Labatut & George Mattheolabakis. (2018) Non-viral based miR delivery and recent developments. European Journal of Pharmaceutics and Biopharmaceutics 128, pages 82-90.
Crossref
Wen-Juan Ni, Ying-Zhong Wu, Dong-Hong Ma & Xiao-Min Leng. (2018) Noncoding RNAs in Calcific Aortic Valve Disease: A Review of Recent Studies. Journal of Cardiovascular Pharmacology 71:5, pages 317-323.
Crossref